Helicos BioSciences Corporation

Helicos BioSciences Announces Shipment of the World's First Single Molecule DNA Sequencer

Helicos BioSciences Announces Shipment of the World's First Single Molecule DNA Sequencer

March 5, 2008

First customer shipment marks a major inflection point in Genomic Analysis and a significant step toward the $1,000 Genome

BG Medicine, Inc.

Takeda Joins the HRP Initiative to Discover Biomarkers of High-Risk Atherosclerotic Plaque

Takeda Joins the HRP Initiative to Discover Biomarkers of High-Risk Atherosclerotic Plaque

April 1, 2008

Collaborative venture is focused on identifying individuals at high risk of heart attack or stroke to facilitate drug development and enabling the rapid discovery and development of new treatments that can prevent the first event.

Helicos BioSciences Corporation

Helicos BioSciences Announces Single Molecule DNA Sequence Data Published in Science Magazine

Helicos BioSciences Announces Single Molecule DNA Sequence Data Published in Science Magazine

April 3, 2008

Data Validates the World's First Single Molecule Sequencing of an Organism

Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Announces Appointment of Guy Macdonald as President and Chief Executive Officer

Tetraphase Pharmaceuticals Announces Appointment of Guy Macdonald as President and Chief Executive Officer

April 9, 2008

Industry Veteran to Lead Advancement of Company’s Breakthrough, Synthetic Chemistry Platform

VisEn Medical, Inc.

VisEn Medical Launches FMT™ 2500 – Next-Generation Fluorescence Imaging System

VisEn Medical Launches FMT™ 2500 – Next-Generation Fluorescence Imaging System

April 14, 2008

New Instrument Generates Real-Time In Vivo Data via Quantitative Tomography

VisEn Medical, Inc.

VisEn Medical Raises $5.0 Million in Expanded Series B Financing

VisEn Medical Raises $5.0 Million in Expanded Series B Financing

April 18, 2008

Woburn, MA, April 18, 2008 -- VisEn Medical, Inc., a leader in fluorescence in vivo imaging, today announced the expansion of its Series B financing. Merck Capital Ventures and Flagship Ventures co-led this $5.0 million expansion of the Series B round, which initially raised $7 million in November 2007, bringing the total Series B financing amount to $12.0 million. VisEn will use the additional financing to further advance its proprietary fluorescence in vivo imaging product pipelines, and to expand its commercial applications and customer support of its marketed products worldwide.

Resolvyx Pharmaceuticals, Inc.

Resolvyx Pharmaceuticals Strengthens Its Board of Directors with Industry Leaders

Resolvyx Pharmaceuticals Strengthens Its Board of Directors with Industry Leaders

April 22, 2008

BEDFORD, Mass.--(BUSINESS WIRE)--Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced the appointment of Timothy J. Barberich and George M. Milne, Jr., Ph.D, to Resolvyx's Board of Directors. Resolvyx is focused on developing drugs based on resolvins, a recently discovered family of naturally-occurring, small molecule lipid mediators that actively resolve inflammation and can be targeted to treat a wide range of diseases, including asthma, cardiovascular disease and multiple eye diseases.

Resolvyx Pharmaceuticals, Inc.

Resolvyx Pharmaceuticals Raises $25 Million in Series B Financing

Resolvyx Pharmaceuticals Raises $25 Million in Series B Financing

April 22, 2008

Company Advancing Resolvin Therapeutics to Initiate Human Clinical Trials in 2008

Black Duck Software, Inc.

Black Duck Software Acquires Software Code Search Leader Koders

Black Duck Software Acquires Software Code Search Leader Koders

April 28, 2008

WALTHAM, Mass. - (Business Wire) Black Duck Software, the leading global provider of products and services for accelerating software development through the managed use of open source software, today announced it has acquired the assets of Koders as well as the company’s popular on-line search engine for open source software and other web-downloadable code. Black Duck will improve the free online search site and incorporate Koders’ search capability into its highly successful open source product portfolio.

Helicos BioSciences Corporation

Helicos BioSciences Reports Q1 2008 Financial Results

Helicos BioSciences Reports Q1 2008 Financial Results

April 29, 2008

CAMBRIDGE, Mass., Apr 29, 2008 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its financial results for the quarter ended March 31, 2008.